Difficulty: Medium
Average Score: 71%
Practice
A 66-year-old woman is seen in clinic for a new diagnosis of epilepsy; she has recurrent partial seizures attributed to a left hemispheric stroke. She has atrial fibrillation (on warfarin), osteoporosis, and a history of kidney stones. Phenytoin caused a rash. Which of the following is the most appropriate antiepileptic medication for this patient?
Correct answer
B
Rationale
The most appropriate antiepileptic medication for the 66-year-old woman with a history of epilepsy due to a left hemispheric stroke, atrial fibrillation, osteoporosis, and a previous rash with phenytoin is levetiracetam (Option B). Levetiracetam is a broad-spectrum antiepileptic drug with minimal drug interactions, making it suitable for patients with multiple comorbidities like atrial fibrillation and osteoporosis. Additionally, it has a lower risk of causing adverse skin reactions compared to carbamazepine and primidone, making it a safer choice given the patient's history of a rash with phenytoin. Valproate (Option D) is contraindicated in patients with a history of kidney stones due to its potential to increase the risk of renal calculi formation.
Educationally, understanding the rationale behind selecting the appropriate antiepileptic medication for a specific patient is crucial in optimizing treatment outcomes and minimizing adverse effects. Considering a patient's comorbidities, previous medication reactions, and contraindications is essential in making informed pharmacological decisions. This case highlights the importance of tailoring treatment plans to individual patient profiles to ensure the best therapeutic outcomes while minimizing risks.
Educationally, understanding the rationale behind selecting the appropriate antiepileptic medication for a specific patient is crucial in optimizing treatment outcomes and minimizing adverse effects. Considering a patient's comorbidities, previous medication reactions, and contraindications is essential in making informed pharmacological decisions. This case highlights the importance of tailoring treatment plans to individual patient profiles to ensure the best therapeutic outcomes while minimizing risks.